Skip to main content

Arthur Grossman, Chung-Soon Im

Solazyme has appointed Arthur Grossman as chief of genetics, the Menlo Park, Calif.-based company said last week. Grossman is a senior staff scientist at the Carnegie Institution and a professor of biological sciences at Stanford University.
Solazyme said Grossman will retain his academic positions but will split time with the company. At Solazyme, Grossman will oversee R&D projects and development strategies. He was formerly chair of Solazyme’s scientific advisory board.
In addition, Chung-Soon Im has joined Solazyme as a scientist. According to the firm, Im is an algal geneticist with expertise in the areas of algal genetic engineering, algal microarray technology, and the characterization of genetic pathways involved in the biosynthesis of high value algal materials.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.